IgA nephropathy is an autoimmune kidney disease, and complement, a component of the innate immune system, plays a role in the condition's pathogenesis. Investigators have developed and tested a novel gene therapy that enters kidney cells and enables them to block complement activation. The research was presented at ASN Kidney Week 2024, held October 23–27.
from Medical Xpress - latest medical and health news stories https://ift.tt/f62viFY
